Atopic Dermatitis Clinical Trials

Find Atopic Dermatitis Clinical Trials Near You

French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)

Status: Recruiting
Location: See all (62) locations...
Study Type: Observational
SUMMARY

The objective of the study is to describe the therapeutic management of patients more than or equal to 18 years old eligible for systemic therapy or treated by systemic therapy for atopic dermatitis (AD). This study will be proposed to a sample of French dermatologists experienced in the management of AD, practicing in hospital centers and/or office-based dermatologists. The study will be conducted in real conditions of practice, systemic treatment decisions will be taken at the sole initiative of the participating physician irrespective of the patient enrollment decision. Each patient will be followed-up in routine care setting for 1 year.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Signed informed consent form.

• Patient with moderate to severe AD according to the Investigator's judgment and

‣ Patient eligible to systemic treatment as Atopic Dermatitis Control Tool (ADCT) more than or equal to (≥) 7 and/or use topical corticosteroids (TCS) more than (\>) 90 gram (g)/month and/or TCS are not advisable.

‣ or

⁃ Patient currently under systemic treatment.

• Able to understand and complete study-related questionnaires.

Locations
Other Locations
France
Investigational Site Number: 2500051
RECRUITING
Aix-en-provence
Investigational Site Number: 2500023
RECRUITING
Amiens
Investigational Site Number: 2500004
RECRUITING
Angers
Investigational Site Number: 2500017
RECRUITING
Angers
Investigational Site Number: 2500050
RECRUITING
Arès
Investigational Site Number: 2500063
RECRUITING
Arès
Investigational Site Number: 2500054
RECRUITING
Bayonne
Investigational Site Number: 2500043
RECRUITING
Bezannes
Investigational Site Number: 2500040
RECRUITING
Biarritz
Investigational Site Number: 2500036
RECRUITING
Bordeaux
Investigational Site Number: 2500053
RECRUITING
Bordeaux
Investigational Site Number: 2500013
RECRUITING
Chalon-sur-saône
Investigational Site Number: 2500026
RECRUITING
Chalon-sur-saône
Investigational Site Number: 2500046
RECRUITING
Chalon-sur-saône
Investigational Site Number: 2500041
RECRUITING
Châlons-en-champagne
Investigational Site Number: 2500018
RECRUITING
Cherbourg
Investigational Site Number: 2500020
RECRUITING
Cholet
Investigational Site Number: 2500048
RECRUITING
Clermond Ferrand
Investigational Site Number: 2500059
RECRUITING
Contamine-sur-arve
Investigational Site Number: 2500010
RECRUITING
Dunkirk
Investigational Site Number: 2500047
RECRUITING
Estrées-deniécourt
Investigational Site Number: 2500049
RECRUITING
Fort-de-france
Investigational Site Number: 2500032
RECRUITING
La Ravoire
Investigational Site Number: 2500044
RECRUITING
La Ravoire
Investigational Site Number: 2500011
RECRUITING
La Roche-sur-yon
Investigational Site Number: 2500037
RECRUITING
La Tronche
Investigational Site Number: 2500001
RECRUITING
Le Mans
Investigational Site Number: 2500056
RECRUITING
Le Mans
Investigational Site Number: 2500068
RECRUITING
Le Mans
Investigational Site Number: 2500012
RECRUITING
Le Puy-en-velay
Investigational Site Number: 2500003
RECRUITING
Limoges
Investigational Site Number: 2500031
RECRUITING
Loperhet
Investigational Site Number: 2500060
RECRUITING
Marseille
Investigational Site Number: 2500055
RECRUITING
Monaco
Investigational Site Number: 2500058
RECRUITING
Mont-de-marsan
Investigational Site Number: 2500070
RECRUITING
Mont-saint-aignan
Investigational Site Number: 2500033
RECRUITING
Niort
Investigational Site Number: 2500005
RECRUITING
Paris
Investigational Site Number: 2500009
RECRUITING
Paris
Investigational Site Number: 2500030
RECRUITING
Paris
Investigational Site Number: 2500065
RECRUITING
Paris
Investigational Site Number: 2500071
RECRUITING
Paris
Investigational Site Number: 2500027
RECRUITING
Périgueux
Investigational Site Number: 2500028
RECRUITING
Périgueux
Investigational Site Number: 2500029
RECRUITING
Rennes
Investigational Site Number: 2500035
RECRUITING
Rennes
Investigational Site Number: 2500021
RECRUITING
Romans-sur-isère
Investigational Site Number: 2500022
RECRUITING
Rouen
Investigational Site Number: 2500025
RECRUITING
Saint-etienne
Investigational Site Number: 2500062
RECRUITING
Saint-gervais-les-bains
Investigational Site Number: 2500076
RECRUITING
Saint-martin
Investigational Site Number: 2500008
RECRUITING
Saint-maur-dès-faussés
Investigational Site Number: 2500034
RECRUITING
Saint-maur-des-fossés
Investigational Site Number: 2500045
RECRUITING
Saint-quentin
Investigational Site Number: 2500057
RECRUITING
Sainte-eulalie
Investigational Site Number: 2500019
RECRUITING
Sainte-maxime
Investigational Site Number: 2500015
RECRUITING
Toulouse
Investigational Site Number: 2500016
RECRUITING
Tours
Investigational Site Number: 2500038
RECRUITING
Vannes
Investigational Site Number: 2500024
RECRUITING
Villefranche-sur-saône
Investigational Site Number: 2500052
RECRUITING
Villeurbanne
Investigational Site Number: 2500066
RECRUITING
Villeurbanne
Contact Information
Primary
Trial Transparency email recommended (Toll free for US & Canada)
Contact-US@sanofi.com
800-633-1610
Time Frame
Start Date: 2025-02-04
Estimated Completion Date: 2027-05-13
Participants
Target number of participants: 600
Treatments
Atopic Dermatitis
The study plans to collect information on patients during visits according to clinical practice. Enrolled patients will receive AD treatment of marketed drugs prescribed by the specialty physician. No investigational drug will be given for the purpose of this study.
Related Therapeutic Areas
Sponsors
Leads: Sanofi

This content was sourced from clinicaltrials.gov